Table 6 Total number of patients screened over 3 years: Incident patients distributed per metastatic/non-metastatic condition and screening strategy
Incident patients | Patients in 3 years | ||
|---|---|---|---|
32 months - Current strategy | metastatic | 12.8 (12.5–13.2) | 30,000 |
Pr(CI 95%) | non-metastatic | 25.9 (25.7–26.1) | |
22-months strategy | metastatic | 14.9 (14.7–15.1) | 45,000 |
Pr(CI 95%) | non-metastatic | 43.2 (43.1–43.3) | |
16-months strategy | metastatic | 11.2 (11.1–11.3) | 60,000 |
Pr(CI 95%) | non-metastatic | 66.3 (66.2–66.4) |